Chemo infusion into liver for colorectal cancer spread
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a strong chemotherapy combination given directly into the liver's blood supply (called HAIC) for people whose colorectal cancer has spread only to the liver and cannot be removed with surgery yet. The goal is to shrink the liver tumors enough so they can be surgically removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old
- You have colorectal cancer that has spread only to the liver (not to other organs)
- You have at least one measurable tumor in the liver
- Your heart, lungs, liver, kidneys, and blood counts are within healthy limits (your doctor will test this)
- You have not had prior surgery, ablation, or radiation to remove liver tumors from colorectal cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment given directly into the liver after surgery to remove colorectal cancer that has spread to the liver. The goal is to see if this treatment lowers the chance of the cancer coming back.
This trial tests whether giving chemotherapy directly into the liver after surgery can lower the chance of cancer coming back. It is for people who had multiple liver tumors removed and whose cancer did not grow during pre-surgery chemo.
This trial tests whether adding a special chemotherapy pump implanted in your liver (hepatic arterial infusion) to standard chemotherapy works better than standard chemotherapy alone for people whose colorectal cancer has spread only to the liver and cannot be removed by surgery. The pump delivers high doses of chemo directly to the liver to shrink tumors and possibly control the disease longer.
This trial is testing a new way to give the chemotherapy drug paclitaxel directly into the liver (through a tiny tube) along with standard systemic treatment for people whose colorectal cancer has spread only to the liver and cannot be surgically removed. The goal is to see if this targeted approach works better than standard treatment alone.
This Phase 3 trial tests different ways to deliver chemotherapy for colon cancer that has spread only to the liver (with limited possible tiny lung spots). It looks at whether the treatment plan improves outcomes compared with another chemotherapy approach, using oxaliplatin and LV5FU2 (with or without irinotecan) plus an added targeted medicine.
This Phase 3 trial tests a treatment approach for colorectal cancer that cannot be removed with surgery at first but has spread only to the liver. It is intended for people whose tumor is RAS/BRAF “wild-type” and who are well enough to do daily activities, to see if the treatment can control the cancer better.
Hear when a new Colorectal Liver Metastasis (CRLM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.